-transparent.png){kind=logo}
A randomized double-blind trial was performed to evaluate the efficacy of a new non-steroidal anti-inflammatory analgesic drug, ketorolac, in the treatment of cancer pain compared with the opioid pentazocine. A total of 40 patients with moderate to severe cancer pain were studied, 20 patients being treated with 10 mg ketorolac given orally every 6 h and 20 receiving 50 mg pentazocine given orally every 6 h for up to 7 days. A reduction in the severity of the pain was recorded in both treatment groups with no significant difference in efficacy being found between the two therapies, although withdrawals due to adverse reactions were significantly less in the ketorolac-treated group (p less than 0.005). It is concluded that ketorolac may be a useful and more acceptable alternative to opioids in the treatment of cancer pain.
J Estapé, and
N Viñolas, and
B González, and
F Inglés, and
T Bofill, and
M C Guzmán, and
E Tarragó
January 1991,
Current medical research and opinion,
J Estapé, and
N Viñolas, and
B González, and
F Inglés, and
T Bofill, and
M C Guzmán, and
E Tarragó
September 1965,
JAMA,
J Estapé, and
N Viñolas, and
B González, and
F Inglés, and
T Bofill, and
M C Guzmán, and
E Tarragó
October 1990,
British journal of anaesthesia,
J Estapé, and
N Viñolas, and
B González, and
F Inglés, and
T Bofill, and
M C Guzmán, and
E Tarragó
August 1965,
Journal of the American Geriatrics Society,
J Estapé, and
N Viñolas, and
B González, and
F Inglés, and
T Bofill, and
M C Guzmán, and
E Tarragó
August 1967,
Praxis,
J Estapé, and
N Viñolas, and
B González, and
F Inglés, and
T Bofill, and
M C Guzmán, and
E Tarragó
June 2016,
Canadian journal of anaesthesia = Journal canadien d'anesthesie,
J Estapé, and
N Viñolas, and
B González, and
F Inglés, and
T Bofill, and
M C Guzmán, and
E Tarragó
November 1964,
Svenska lakartidningen,
J Estapé, and
N Viñolas, and
B González, and
F Inglés, and
T Bofill, and
M C Guzmán, and
E Tarragó
July 1964,
JAMA,
J Estapé, and
N Viñolas, and
B González, and
F Inglés, and
T Bofill, and
M C Guzmán, and
E Tarragó
February 2022,
Trials,
J Estapé, and
N Viñolas, and
B González, and
F Inglés, and
T Bofill, and
M C Guzmán, and
E Tarragó
January 1983,
The Journal of international medical research,
